|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.54 USD | -0.91% |
|
+0.74% | +22.64% |
| Market Cap | 9.79B 8.51B 7.92B 7.27B 13.73B 935B 13.95B 93.38B 36.65B 465B 36.77B 35.96B 1,560B | P/E 2026 * |
12.4x | P/E 2027 * | 9.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.11B 9.66B 8.99B 8.26B 15.59B 1,061B 15.83B 106B 41.6B 528B 41.73B 40.82B 1,771B | EV / Sales 2026 * |
6.29x | EV / Sales 2027 * | 4.99x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -0.91% | ||
| 1 week | +0.74% | ||
| 1 month | +7.18% | ||
| 3 months | +29.05% | ||
| 6 months | +15.10% | ||
| Current year | +22.64% |
| 1 week | 81.21 |  | 84.44 |
| 1 month | 73.89 | | 84.44 |
| Current year | 61.32 | | 84.44 |
| 1 year | 58.68 | | 84.44 |
| 3 years | 32.83 | | 84.44 |
| 5 years | 29.85 | | 84.44 |
| 10 years | 8.18 | | 84.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% | ||
| 7/1/26 | Free | Chief Financial Officer | 168,986 | 0.1425% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.91% | +0.74% | +39.85% | +95.22% | 9.79B | |
| +0.32% | -0.66% | +64.21% | +23.67% | 322B | |
| +0.21% | +2.87% | +33.60% | -10.34% | 71.6B | |
| -3.60% | -2.43% | -1.16% | -6.92% | 8.39B | |
| +1.80% | -1.99% | -15.78% | -12.22% | 4.3B | |
| -0.68% | -1.87% | -34.78% | +3.04% | 3.81B | |
| +3.08% | -1.41% | -12.94% | +9.52% | 3.58B | |
| -2.15% | -3.40% | +25.70% | +40.83% | 2.59B | |
| +0.85% | +9.88% | -0.25% | -7.32% | 2.25B | |
| -.--% | +4.37% | -22.39% | -17.54% | 1.76B | |
| Average | -0.11% | -0.10% | +7.61% | +11.80% | 42.96B | |
| Weighted average by Cap. | +0.21% | -0.08% | +54.03% | +18.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.54B 1.43B 1.31B 2.48B 169B 2.52B 16.86B 6.62B 84.01B 6.64B 6.49B 282B | 2B 1.74B 1.62B 1.49B 2.81B 191B 2.86B 19.12B 7.5B 95.26B 7.53B 7.36B 319B |
| Net income | 812M 706M 657M 603M 1.14B 77.52B 1.16B 7.75B 3.04B 38.59B 3.05B 2.98B 129B | 1.03B 899M 837M 768M 1.45B 98.72B 1.47B 9.86B 3.87B 49.15B 3.88B 3.8B 165B |
| Net Debt | 1.32B 1.15B 1.07B 982M 1.86B 126B 1.88B 12.61B 4.95B 62.85B 4.97B 4.86B 211B | 205M 178M 166M 152M 287M 19.56B 292M 1.95B 767M 9.74B 769M 752M 32.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$82.54 | -0.91% | 1,565,028 |
| 26-07-30 | US$83.30 | +0.02% | 2,135,849 |
| 26-07-29 | US$83.28 | -0.20% | 1,634,260 |
| 26-07-28 | US$83.45 | +2.41% | 2,623,608 |
| 26-07-27 | US$81.48 | -0.55% | 1,435,892 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
